Reference
Toyoda H, et al. Weekly rituximab followed by monthly rituximab treatment for autoimmune disease associated with RAS-associated autoimmune leukoproliferative disease. Journal of Pediatric Hematology/Oncology 40: e516-e518, No. 8, 1 Nov 2018. Available from: URL: http://doi.org/10.1097/MPH.0000000000001276 - Japan
Rights and permissions
About this article
Cite this article
Cyclophosphamide/mycophenolate mofetil. Reactions Weekly 1730, 107 (2018). https://doi.org/10.1007/s40278-018-55007-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-55007-x